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Materials and methods. From August 2009 to August 2013, 38 NPC patients were treated with Linac (32%) and HT (68%), 34 males
and 4 females, with a median age of 51 years (range, 15–78years). Tumor stage: I: 5%; II: 18%; III: 34%; IVa: 34%; IVb: 8%, according
to AJCC 7th ed. Histopathological analysis revealed that 42% were undifferentiated carcinomas, 26% linfoepiteliomas and 32%
squamous cell carcinomas. Median radiation dose of 70Gy to gross tumor volume and positive neck nodes, 66Gy to clinical
target volume, and 54Gy to clinically negative neck, in 33 fractions was delivered. Ninety percent of patients received concurrent
platinum-based chemotherapy. Side-effects were evaluated according to RTOG criteria.
Results. Acute RTOG complicationswere: Grade 1–2 in 76% of patients (radiodermatitis n=22,mucositis n=17, nausea n=1, aplasia
n=1), Grade 3 in 58% (radiodermatitis n=5, mucositis n=20, aplasia n=1), Grade 4 in 11% (aplasia: n=4). Late RTOG complications
were: Grade 1–2 in 74% (xerostomia n=28), Grade 3 in 11% (xerostomia: n=4) and Grade 4 in 3% (dysphagia n=1). Acute or
late Grade 5 complications, mandibular osteorradionecrosis or temporo-mandibular joint dysfunction were not observed. After
a median follow-up of 18 months, the 3-year actuarial local, locoregional and distant control rates were 89%, 95%, and 94%
respectively and the 3-year actuarial progression free survival and overall survival rates were 72% and 85% respectively.
Conclusions. Effectivity in terms of tolerance is compared favourablywith conventional radiotherapy showing in our data excellent
rates of tumor response. Not an increase of the acute toxicity and acceptable late toxicity rates support the IMRT in NPC.
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Introduction. IMRT, IGRT and 18FDG PET-CT planning in patients with nasopharyngeal carcinoma have shown a contribution not
only in the accuracy when outlining target volumes but also in the delivery of the radiation treatment and therefore reducing
dose in organs at risk.
Aim. Assess clinical and dosimetric outcomes as well as toxicity in the setting of patients with NC.
Methods. All patients with NC treated with radiotherapy have been included in this analysis.
Results. A total of 18 patients with NC have been treated between April 2008 and September 2012 with radical intention. The
average age was 54 years (range 31–70) and the 77.7% of patients had positive nodes at diagnosis. The 94.4% of the sample
received concomitant Chemotherapy and 16 out of the 18 (88.9%) used a gastrostomy feeding tube. All the patients received
radiation therapy with Steep and Shoot IMRT and planning simulation was performed with 18FDG PET-CT in the 72.2% of the
sample. The prescription dose was 66Gy in 30 fractions with and integrated boost of 2.2Gy per fraction in areas with macroscopic
involvement and 54–60Gy in 30 fractions of 1.8–2Gy per fraction in the regions at risk of microscopic spread. IGRT (Cone Beam
CT) was used for treatment veriﬁcation in all the cases. DVH were assessed according to institutional constraints. The mean
follow up was 14.6 months (median: 8 months; range: 1.4–51.17 months). 1 year local failure free survival (LFFS) is 100% and the
2-year actuarial LFFS is 75%. G3 and G4 acute mucositis was 50% and 5.6% respectively. The 83.3% completed treatment without
interruptions.
Conclusion. IMRT, IGRT and 18FDG PET-CT are perfectly integrated in the clinical management of patients with NC allowing
acceptable clinical and dosimetric results.
http://dx.doi.org/10.1016/j.rpor.2013.03.293
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Introduction. Early stage glottis cancer can be successfully treated with radiotherapy. The 5-year disease-speciﬁc survival rate is
90%. It seems that with treatment by radiotherapy we achieve good rates of local control, nevertheless, we live now in commu-
nication era, the success of our treatment depends also on one of the most important parameters in the quality of live for our
patients: the preservation of voice quality.
Objective. To present the design of a pioneering prospective study that will analyze with a multidisciplinary approach the func-
tional results (voice quality), oncology results and the quality of life in patients diagnosed of early glottis cancer and treated
exclusively with radiation.
Material and methods. Male patients diagnosed of early vocal cord carcinoma (T1–T2 N0M0), in whom radiation therapy is the
deﬁnitive treatment decided at the Head&Neck tumour-board. The patients will be studied at the voice unit of otolaryngology
clinic and will have aerodynamic test, perceptual voice valuation, registration of changes in prosody rhythm, digitized acoustic
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analysis of the spontaneous speech concatenated with vowel maintained (according to mathematical model of Youri Maryn
y cols: AVQ1) and videoestroboscopy protocol. Furthermore, a completed analysis and history of referral data of toxicity and
oncology results will be done including questionnaires of quality of life (Voice Handicap Index and Voice Activity Participation
Proﬁle). Patients will be evaluated pre-treatment, and 3, 12 and 24 months after treatment.
Conclusion. The study is in the inclusion-phase (n=8,minimumexpected sample n=30) however, preliminary results demonstrate
that the acoustic algorithm is an objective and effective measurement of the evolutionary changes of vocal dynamics caused by
irradiation, presenting high correlation with the perceptual valuation and quality of life index. Note: acoustic algorithm pre and
post-treatment of one of the patients will be shown in the Congress by audio archives and images of videoestroboscopy images.
http://dx.doi.org/10.1016/j.rpor.2013.03.294
Volumetric changes in the GTV during radiotherapy in H&N tumours
Á. Navarro Bergadá1, M. Soler Tortosa1, M. Masiá Tarazona1, Á. Gaitán Toledo1, F. Candela Rodríguez2,
S. Gil Tomás2, M. Marco2, M. López Mun˜oz1, J. Monroy Antón1, M. Estornell Gualde1, M. Melchor In˜íguez2
1 Hospital de la Ribera, Oncología Radioterápica
2 Hospital de la Ribera, Radiofísica
Introduction. In patientswith head andneck (H&N) tumours, the variations of the tumour’s volume as response to the radiotherapy
during the treatment, should be measurable in order to decrease the dose and positioning uncertainties.
Objective. The principal aim of this study is to check the volumetric changes of the GTV during the treatment.
Methods. Between December, 2010 and July, 2012, we included 20 diagnosed patients of H&N tumours at stages III and IV: 3
oral cavities, 2 salivary glands, 2 hipopharynxes, 2 supraglotic larynxes, 2 nasopharynxes, 2 unknown origin tumours of H&N,
and 7 oropharynxes. All of them received conservative treatment with concomitant chemoradiotherapy. Operated tumours,
neoadjuvant chemotherapy, and palliative treatments were excluded. We realized CT for 3D planning with photon ﬁelds. We
used magnetic resonance (MR) for fusion in 6 cases. Later on, we projected three CTs in the course of treatment in order to check
the GTVs volume variations.
Results. The average of time for treatments was 48,10 days (38–57). The CTs for veriﬁcation, were done after an average of 9 (5–24),
14 (10–29) and 23 (16–35) days, with an average of accumulated doses at the time of realizing the CTs of 18.10 (10–48), 29.12 (20–58)
and 46.7Gy (36–70) for the ﬁrst, second and third CT respectively. The GTVs delineated using the ﬁrst, second and third CT were,
for average term, 79.83% (44–150), 68.79% (36–199) and 52.09% (18–122) of the original GTVs contoured in the planning CTs.
Conclusion. The volumetric changes of the GTVs during the radiotherapy are evident, and it is convenient to control them during
the treatment in order to consider adjustments in the planning. The addition of imaging tests like PET or MR probably would
help to optimize and give more precise contouring of the volumes during the treatment.
http://dx.doi.org/10.1016/j.rpor.2013.03.295
